| 2922.50.25 | 00 | Other | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 82% |
| 2922.50.35 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4￠/kg + 50% |
| 2922.50.40 | 00 | Other | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 0.2￠/kg + 3.1% (SG) | 15.4￠/kg + 50% |
| 2922.50.50 | 00 | Other | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 30.5% |
| 2923.20.10 | 00 | Purified egg phospholipids, pharmaceutical grade meeting requirements of the U.S. Food and Drug Administration, for use in intravenous fat emulsion | kg | Free | | 16.5￠/kg + 30% |
| 2923.20.20 | 00 | Other | kg | 5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 33.4% |
| 2923.90.00 | 00 | Other | kg | 6.2% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 15.4￠/kg + 36% |
| 2924.19.11 | 50 | Other | kg | | | |
| 2924.19.80 | 00 | Other | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 30.5% |
| 2924.21.12 | 00 | 1-(2-Methylcyclohexyl)-3-phenylurea | kg | Free | | 15.4￠/kg + 48.5% |
| 2924.21.16 | 00 | Other | kg | 6.5% | Free (A*,AU,BH, CA,CL,E,IL,J,JO, K,MA,MX,P) 2.9% (SG) | 15.4￠/kg + 48.5% |
| 2924.21.18 | 00 | sym-Diethyldiphenylurea | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2￠/kg + 3.3% (SG) | 15.4￠/kg + 58% |
| 2924.21.20 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4￠/kg + 58% |
| 2924.21.45 | 00 | Other | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 0.2￠/kg + 3.3% (SG) | 15.4￠/kg + 58% |
| 2924.21.50 | 00 | Other | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 30.5% |
| 2924.23.10 | 00 | 2-Acetamidobenzoic acid | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX,P) 0.2￠/kg + 3.3% (SG) | 15.4￠/kg + 58% |
| 2924.23.70 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4￠/kg + 58% |
| 2924.23.75 | 00 | Other | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 0.2￠/kg + 3.3% (SG) | 15.4￠/kg + 58% |
| 2924.29.05 | 00 | Biligrafin acid; 3,5-Diacetamido-2,4,6-triiodobenzoic acid; and Metrizoic acid | kg | 5.3% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 34% |
| 2924.29.36 | 00 | Other | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 3% (SG) | 15.4￠/kg + 60% |
| 2924.29.47 | 00 | Other | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 2.9% (SG) | 15.4￠/kg + 64.5% |
| 2924.29.62 | | Other | | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 15.4￠/kg + 47.5% |
| 2924.29.62 | 10 | Acetaminophen | kg | | | |
| 2924.29.62 | 50 | Other | kg | | | |
| 2924.29.71 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4￠/kg + 58% |
